Telesis Bio Inc (TBIO) Quote

$tbio

Telesis intends to file a Form 25 with the Securities and Exchange Commission (the "SEC") to remove its Common Stock from listing on the Nasdaq Global Select Market on or about September 20, 2024. As a result,— sahm.t (@M1000Sahm) September 19, 2024

Don’t forget it’s getting delisted tomorrow

tbio................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783

Wow field day

TBIO $3.40 + 150% cash out time pump time over

TBIO 3.80 + 180% push it more honest hedge funds we luv it

Pump it more $3.20 + 120% now. I luv Gary Gensler

Pump it up

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market

What’s the deal with this sucker

Lol

Don’t blink

somebody is getting smoked here

5.50s

Anyone have a clue as to why the jump today?

Go. TBiO. Life. Enhancing. Patent

I personally see this consolidating Monday between .55 and .45

TBIO...............................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783

This one scares the crap out of me...

Imagine replication of COVID ( or the next worst thing) with out a biological matrix.

December 5, 2023 | LIVE WEBINAR
Unlocking the Potential of mRNA as a Tool for Immuno-Oncology Therapy Discovery and Development
Immuno-oncology is a rapidly growing area for therapeutic development. With the adoption of various autologous cell therapies and an increased focus on more broadly applicable allogeneic treatments and multi-specific therapies, the complexity of these development activities is also increasing. With this drive to increased complexity and the inherent risks associated with potential failure in Phase 1 clinical trials, it is critical to have a solid scientific foundation for the development of these next-generation immunotherapies. This talk will focus on how to overcome the limitations associated with traditional viral vector based recombinant TCR gene expression to build hundreds of candidates a week, resulting in improved confidence in screening and lead optimization. With the direct use of mRNA to drive transient modulation of cellular phenotypes, potential candidates can be screened quickly and cost-effectively. Come and learn how immuno-oncology researchers are automating synthetic biolological...



$TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024

Wow, a patent to clone that’s incredible

Gosh. Such wisdom. Thanks for enlightening us with that critical information.

dilutive bio stocks under 1.00 are like pink sheets on steroids...ya better know how to trade em or you will lose yo money fast!!!

TBIO: Right here in my San Diego --- grab some?????

Chart plays are never tricky. Stick to bullish stocks. Day trading pop and drops, ya better have skills and understand intraday 60 min charting, order flow and how to spot the shorts.

Tricky day

New highs AH

LETS JUST SAY MOST AH POPS ARE DILUTION, ESPECIALLY THE BIO SPACE.

THX

Another short opp

AFTER HOUR DILUTION TAKING PLACE...CHASE AND CRY PLAY!

What leaked?

Nice one!

TBIO: VIBRIO NATRIEGENS (So, what's NEW, Pussycat??!!)

$TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024

Anyone know why the huge jump in price and volume?